Nasia Safdar, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Nasia Safdar has been the Medical Director of Infection Control at UW Hospital and Clinics since 2009. She came to Wisconsin in 1997 for her residency and fellowship. She is board certified in infectious disease and she focuses on healthcare-associated infections, particularly in the acute care setting. Dr. Safdar believes that many health care-associated infections can be prevented with adherence to known best practices. As medical director for the department of infection prevention, her job is to lead the department in its mission of reducing healthcare-associated infections by identifying, testing and implementing interventions that have benefit for reducing health care associated infections (HAI).
She is an associate professor of infectious diseases at the University of Wisconsin School of Medicine and Public Health and the Associate Chief of Staff for Research at the William S. Middleton VA Hospital. Her research includes the evaluation of novel and innovative strategies for prevention of HAI. She is currently leading the fecal bacteriotherapy program at UW Hospital and is the principal investigator of a current ongoing VA-funded trial of probiotics for reducing HAI.
UW Health Clinics
UW School of Medicine and Public Health
|Department of Medicine|
Professional Certifications and Education
University of Wisconsin Hospital and Clinics, Madison, WI
University of Wisconsin Hospital and Clinics, Madison, WI
Sir Ganga Ram Hospital, Lahore, Pakistan
Aga Khan University Medical College, Karachi, Pakistan, 1995
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Dr. Safdar is interested in examining the efficacy of novel interventions to reduce healthcare-associated infection such as the use of probiotics for reducing colonization by methicillin-resistant Staphylococcus aureus and Clostridium difficileand has ongoing trials in this area.
Caya T Musuuza J Yanke E Schmitz M Anderson B Carayon P Safdar N .
Using a Systems Engineering Initiative for Patient Safety to Evaluate a Hospital-wide Daily Chlorhexidine Bathing Intervention. J Nurs Care Qual. 2015 Oct-Dec;30(4):337-44
[PubMed ID: 26035708]
Blakney R Yanke E Fink C Wigton R Safdar N .
Optimizing diagnostic testing for Clostridium difficile: The perceptions of physicians and nurses on when to order testing for C difficile. Am J Infect Control. 2015 Aug 1;43(8):889-91
[PubMed ID: 25957816]
Blakney R Gudnadottir U Warrack S O'Horo JC Anderson M Sethi A Schmitz M Wang J Duster M Ide E Safdar N .
The relationship between patient functional status and environmental contamination by Clostridium difficile: a pilot study. Infection. 2015 Aug;43(4):483-7
[PubMed ID: 25869819]
Barker A Duster M Valentine S Archbald-Pannone L Guerrant R Safdar N .
Probiotics for Clostridium difficile infection in adults (PICO): Study protocol for a double-blind, randomized controlled trial. Contemp Clin Trials. 2015 Jul 22;44:26-32
[PubMed ID: 26210512]
Zellmer C Van Hoof S Safdar N .
Variation in health care worker removal of personal protective equipment. Am J Infect Control. 2015 Jul 1;43(7):750-1
[PubMed ID: 26138659]
Becerra MB Becerra BJ Banta JE Safdar N .
Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample. BMC Infect Dis. 2015 Jul 1;15:254
[PubMed ID: 26126606]
Safdar N Perencevich E .
Crossing the quality chasm for Clostridium difficile infection prevention. BMJ Qual Saf. 2015 Jul;24(7):409-11
[PubMed ID: 25979001]
Singh N Winston DJ Limaye AP Pelletier S Safdar N Morris MI Meneses K Busuttil RW Wagener MM Wheat LJ .
Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients. Transplantation. 2015 Jun 4;
[PubMed ID: 26050015]
Morgan DJ Braun B Milstone AM Anderson D Lautenbach E Safdar N Drees M Meddings J Linkin DR Croft LD Pineles L Diekema DJ Harris AD .
Lessons learned from hospital Ebola preparation. Infect Control Hosp Epidemiol. 2015 Jun;36(6):627-31
[PubMed ID: 25994323]
Evans CT Safdar N .
Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection. Clin Infect Dis. 2015 May 15;60 Suppl 2:S66-71
[PubMed ID: 25922403]
Ramanathan S Hill JN Cameron KA Safdar N Guihan M Evans CT .
Relationship between knowledge and attitudes of methicillin-resistant Staphylococcus aureus and hand hygiene behavior in Veterans with spinal cord injury and disorder. Am J Infect Control. 2015 May 1;43(5):537-9
[PubMed ID: 25952051]
Zellmer C Blakney R Van Hoof S Safdar N .
Impact of sink location on hand hygiene compliance for Clostridium difficile infection. Am J Infect Control. 2015 Apr 1;43(4):387-9
[PubMed ID: 25704256]
Yanke E Zellmer C Van Hoof S Moriarty H Carayon P Safdar N .
Understanding the current state of infection prevention to prevent Clostridium difficile infection: a human factors and systems engineering approach. Am J Infect Control. 2015 Mar 1;43(3):241-7
[PubMed ID: 25728149]
Kendall RE Gosser RA Schulz LT Trapskin PJ Caponi B Safdar N .
Anti-diarrheal medication use in the treatment of Ebola virus-induced diarrhea. Travel Med Infect Dis. 2015 Mar-Apr;13(2):205-6
[PubMed ID: 25682446]
Zellmer C Zimdars P Parker S Safdar N .
Evaluating the usefulness of patient education materials on surgical site infection: a systematic assessment. Am J Infect Control. 2015 Feb;43(2):167-8
[PubMed ID: 25541334]
Safdar N O'Horo JC .
The authors reply. Crit Care Med. 2015 Feb;43(2):e51
[PubMed ID: 25599497]
Ziegler MJ Pellegrini DC Safdar N .
Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis. Infection. 2015 Feb;43(1):29-36
[PubMed ID: 25331552]
Codella J Safdar N Heffernan R Alagoz O .
An agent-based simulation model for Clostridium difficile infection control. Med Decis Making. 2015 Feb;35(2):211-29
[PubMed ID: 25112595]
Al-Niaimi AN Ahmed M Burish N Chackmakchy SA Seo S Rose S Hartenbach E Kushner DM Safdar N Rice L Connor J .
Intensive postoperative glucose control reduces the surgical site infection rates in gynecologic oncology patients. Gynecol Oncol. 2015 Jan;136(1):71-6
[PubMed ID: 25263249]
Becerra BJ Becerra MB Safdar N .
A Nationwide Assessment of the Burden of Urinary Tract Infection among Renal Transplant Recipients. J Transplant. 2015;2015:854640
[PubMed ID: 25810918]